Sha S, Liu X, Zhao R, Qing L, He Q, Sun L, et al
Pharmacological attempts to treat obesity have had limited success, with notable adverse effects, rendering bariatric surgery as the only current therapy for substantially improving body weight
On the other hand, Tirzepatide combines this GLP-1 activation with stimulation of GIP receptors, further enhancing feelings of satiety and improving insulin sensitivity
Dont get me wrong here - I always push my patients towards lifestyle interventions before medical treatments
GLP-1s are one of the most powerful tools in modern medicine offering benefits that may extend beyond weight loss to better metabolic health, cardiovascular function, and inflammation reduction
Drug Abuse and Dependence 9.1 Controlled Substance VYVANSE contains lisdexamfetamine, a prodrug of amphetamine, a Schedule II controlled substance